StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
77
This month
1
This year
5
Publishing Date
2023 - 08 - 07
1
2023 - 08 - 01
1
2023 - 07 - 24
1
2023 - 07 - 11
1
2023 - 05 - 10
1
2023 - 05 - 09
1
2023 - 05 - 08
1
2023 - 05 - 04
1
2023 - 05 - 02
1
2023 - 05 - 01
1
2023 - 04 - 20
1
2023 - 04 - 11
1
2023 - 03 - 29
1
2023 - 02 - 28
1
2023 - 02 - 10
1
2023 - 02 - 07
1
2023 - 01 - 17
1
2022 - 11 - 07
1
2022 - 11 - 03
1
2022 - 11 - 01
1
2022 - 10 - 17
1
2022 - 08 - 25
1
2022 - 08 - 09
1
2022 - 08 - 02
1
2022 - 07 - 05
1
2022 - 06 - 29
1
2022 - 06 - 28
1
2022 - 06 - 13
1
2022 - 05 - 16
1
2022 - 05 - 03
1
2022 - 04 - 11
1
2022 - 04 - 04
1
2022 - 03 - 15
1
2022 - 02 - 28
1
2022 - 01 - 22
1
2022 - 01 - 18
1
2021 - 12 - 14
1
2021 - 12 - 07
1
2021 - 11 - 22
1
2021 - 11 - 15
1
2021 - 11 - 08
1
2021 - 11 - 05
1
2021 - 11 - 02
3
2021 - 09 - 29
1
2021 - 09 - 18
2
2021 - 09 - 17
1
2021 - 09 - 16
1
2021 - 08 - 18
1
2021 - 08 - 06
1
2021 - 08 - 05
2
2021 - 08 - 03
1
2021 - 06 - 07
1
2021 - 06 - 04
1
2021 - 05 - 17
1
2021 - 05 - 06
1
2021 - 05 - 04
1
2021 - 04 - 08
1
2021 - 03 - 18
1
2021 - 03 - 16
1
2021 - 01 - 19
1
Sector
Health services
1
Health technology
77
Tags
Agave-201
1
Als
1
Antibody
4
Asco
1
Asia
1
Baricitinib
1
Biocapital
5
Biomarkers
2
Biosimilar
2
Biotech-bay
1
Blood
1
Business
6
Cancer
4
Cardiology
1
Cel
1
Cell
1
Cell carcinoma
1
Ces
1
Chinese
12
Clinical-trials-phase-ii
2
Clinical-trials-phase-iii
1
Communication
1
Communications
4
Corporation
1
Covid
2
Dermatitis
1
Diabetes
3
Disease
1
Earnings
21
Events
1
Financial
21
Financial results
13
Genetown
2
Hypercholesterolemia
2
Ibi306
2
Ibi362
5
Injection
2
Lancet
2
Lung cancer
2
Milestone
4
N/a
41
Obesity
4
Phase 1
5
Phase 2
6
Phase 2 results
2
Phase 2b
3
Phase 3
8
Positive
2
Preclinical
2
Product-news
2
Report
8
Respiratory
2
Results
72
Solid tumors
2
Study
5
Therapy
3
Treatment
5
Trial
3
Update
9
Year
4
Entities
Abbvie inc.
1
Blueprint medicines corporation
1
Deciphera pharmaceuticals, inc.
1
Eli lilly and company
37
Global blood therapeutics, inc.
5
Global cord blood corporation
1
I-mab
1
Incyte corporation
77
Karuna therapeutics, inc.
1
Macrogenics, inc.
6
Merus n.v.
10
Mirati therapeutics, inc.
1
Morphosys ag
13
Novartis ag
9
Novocure limited
1
Pfizer, inc.
1
Replimune group, inc.
1
Sanofi
10
Seagen inc.
1
Syndax pharmaceuticals, inc.
1
Syros pharmaceuticals, inc.
7
Takeda pharmaceutical company limited
10
Xencor, inc.
13
Zai lab limited
1
Symbols
ABBV
92
AEM
51
ALNY
81
AMGN
55
APO
41
ARVL
199
AUY
47
BAM
54
BGNE
52
BMO
41
BMY
73
BNPQF
82
BNPQY
82
BNTX
55
BTG
44
CHRS
48
CYTK
44
DAO
46
ENB
42
FBIO
61
FNCTF
374
FRBA
95
GILD
55
GMAB
48
GOLD
50
INCY
77
IONS
43
JD
43
JKS
43
JNJ
248
LGND
46
LLY
219
LTUM
61
LXRX
41
MDT
45
MDWD
53
MPC
55
MPLX
53
MS
225
NEE
49
NEP
48
NTES
59
NVS
59
NVSEF
44
PAYD
198
PFE
64
PPRUF
89
PPRUY
89
PRVB
46
REGN
88
SNY
393
SNYNF
315
TAK
71
TEVJF
53
TK
49
TNK
48
TTOO
44
UAN
52
XNCR
42
XYF
104
Exchanges
Nasdaq
77
Nyse
53
Crawled Date
2023 - 08 - 08
1
2023 - 08 - 07
1
2023 - 08 - 01
1
2023 - 07 - 24
1
2023 - 07 - 11
1
2023 - 05 - 10
1
2023 - 05 - 09
1
2023 - 05 - 08
1
2023 - 05 - 04
1
2023 - 05 - 02
1
2023 - 05 - 01
1
2023 - 04 - 20
1
2023 - 04 - 11
1
2023 - 03 - 29
1
2023 - 02 - 28
1
2023 - 02 - 10
1
2023 - 02 - 07
1
2023 - 01 - 17
1
2022 - 11 - 07
1
2022 - 11 - 03
1
2022 - 11 - 01
1
2022 - 10 - 17
1
2022 - 08 - 25
1
2022 - 08 - 09
1
2022 - 08 - 02
1
2022 - 07 - 05
1
2022 - 06 - 29
2
2022 - 06 - 13
1
2022 - 05 - 16
1
2022 - 05 - 03
1
2022 - 04 - 11
1
2022 - 04 - 04
1
2022 - 03 - 15
1
2022 - 02 - 28
1
2022 - 01 - 22
1
2022 - 01 - 18
1
2021 - 12 - 14
1
2021 - 12 - 07
1
2021 - 11 - 22
1
2021 - 11 - 15
1
2021 - 11 - 08
1
2021 - 11 - 05
1
2021 - 11 - 02
3
2021 - 09 - 29
1
2021 - 09 - 18
2
2021 - 09 - 17
1
2021 - 09 - 16
1
2021 - 08 - 18
1
2021 - 08 - 06
1
2021 - 08 - 05
2
2021 - 08 - 03
1
2021 - 06 - 07
1
2021 - 06 - 04
1
2021 - 05 - 17
1
2021 - 05 - 06
1
2021 - 05 - 04
1
2021 - 04 - 08
1
2021 - 03 - 18
1
2021 - 03 - 16
1
2021 - 01 - 19
1
Crawled Time
00:00
7
00:20
3
01:00
15
03:00
2
07:00
1
11:00
2
12:00
13
12:15
1
12:20
1
12:30
1
13:00
6
13:30
2
14:00
1
14:20
1
15:00
2
19:00
2
20:00
4
21:00
7
22:00
3
23:00
3
Source
www.biospace.com
36
www.globenewswire.com
12
www.prnewswire.com
29
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
results
symbols :
Incy
save search
Incyte to Report First Quarter Financial Results - April 11, 2024
Published:
2024-04-11
(Crawled : 21:00)
- biospace.com/
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-5.6%
|
O:
0.62%
H:
1.17%
C:
-0.76%
first
report
financial
results
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published:
2024-03-13
(Crawled : 23:00)
- biospace.com/
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-3.27%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-5.01%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
XNCR
|
$18.19
-1.03%
-1.04%
490K
|
Health Technology
|
-20.13%
|
O:
-0.66%
H:
4.19%
C:
3.13%
MOR
|
News
|
$17.97
-0.06%
-0.06%
330K
|
Health Technology
|
-1.1%
|
O:
0.22%
H:
0.22%
C:
-0.93%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-12.49%
|
O:
0.03%
H:
1.47%
C:
-0.72%
year
update
financial
results
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
Published:
2024-02-28
(Crawled : 21:00)
- globenewswire.com
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
-3.47%
|
O:
-0.6%
H:
0.45%
C:
0.08%
MRUS
|
$40.435
1.57%
1.55%
710K
|
Health Technology
|
-16.94%
|
O:
2.3%
H:
0.58%
C:
-2.69%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-13.44%
|
O:
0.38%
H:
0.0%
C:
-3.07%
business
year
update
financial
results
Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities
Published:
2024-02-13
(Crawled : 19:00)
- biospace.com/
TAK
|
News
|
$13.36
0.91%
-0.52%
1.6M
|
Health Technology
|
-6.64%
|
O:
0.14%
H:
0.35%
C:
0.07%
XNCR
|
$18.19
-1.03%
-1.04%
490K
|
Health Technology
|
-11.21%
|
O:
-3.56%
H:
2.91%
C:
-3.34%
MOR
|
News
|
$17.97
-0.06%
-0.06%
330K
|
Health Technology
|
3.69%
|
O:
-0.4%
H:
0.23%
C:
-0.46%
MGNX
|
$15.41
-1.28%
-1.3%
770K
|
Health Technology
|
-14.01%
|
O:
-5.25%
H:
2.94%
C:
2.18%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-10.24%
|
O:
3.8%
H:
1.1%
C:
-1.17%
financial
Incyte to Report Fourth Quarter and Year-End 2023 Financial Results
Published:
2024-01-23
(Crawled : 14:00)
- biospace.com/
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-15.58%
|
O:
0.37%
H:
0.75%
C:
0.23%
report
financial
results
Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications
Published:
2023-12-18
(Crawled : 00:00)
- prnewswire.com
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
28.91%
|
O:
1.61%
H:
1.14%
C:
0.57%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-3.29%
|
O:
1.25%
H:
0.0%
C:
0.0%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-16.66%
|
O:
-0.03%
H:
0.06%
C:
-2.67%
ibi362
obesity
publication
communications
chinese
results
Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Published:
2023-12-06
(Crawled : 01:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.66%
|
O:
-2.77%
H:
0.49%
C:
0.49%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
25.47%
|
O:
0.99%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-0.59%
|
O:
-0.6%
H:
0.0%
C:
0.0%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-5.29%
|
O:
-0.2%
H:
1.7%
C:
1.3%
rient-16
treatment
results
study
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
Published:
2023-11-02
(Crawled : 20:00)
- globenewswire.com
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
26.75%
|
O:
0.97%
H:
0.0%
C:
0.0%
MRUS
|
$40.435
1.57%
1.55%
710K
|
Health Technology
|
84.37%
|
O:
3.51%
H:
9.56%
C:
9.56%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-3.8%
|
O:
0.52%
H:
1.38%
C:
1.11%
business
update
financial
results
Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published:
2023-10-31
(Crawled : 00:00)
- biospace.com/
TAK
|
News
|
$13.36
0.91%
-0.52%
1.6M
|
Health Technology
|
0.0%
|
O:
1.05%
H:
0.74%
C:
0.74%
XNCR
|
$18.19
-1.03%
-1.04%
490K
|
Health Technology
|
5.69%
|
O:
-0.41%
H:
2.1%
C:
1.11%
MOR
|
News
|
$17.97
-0.06%
-0.06%
330K
|
Health Technology
|
130.38%
|
O:
4.23%
H:
0.12%
C:
-1.97%
MGNX
|
$15.41
-1.28%
-1.3%
770K
|
Health Technology
|
198.64%
|
O:
0.0%
H:
2.13%
C:
1.16%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-0.46%
|
O:
-0.39%
H:
4.09%
C:
3.8%
financial
results
Incyte to Report Third Quarter Financial Results - October 10, 2023
Published:
2023-10-10
(Crawled : 13:30)
- biospace.com/
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-8.4%
|
O:
0.48%
H:
1.39%
C:
0.51%
report
financial
results
Innovent Announces 2023 Interim Results and Business Updates
Published:
2023-08-23
(Crawled : 12:00)
- biospace.com/
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-14.36%
|
O:
-0.86%
H:
0.0%
C:
0.0%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-19.86%
|
O:
0.39%
H:
0.37%
C:
-0.6%
business
results
Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results
Published:
2023-08-09
(Crawled : 13:00)
- biospace.com/
PFE
|
News
A
|
$26.26
1.0%
-0.08%
36M
|
Health Technology
|
-26.32%
|
O:
-0.11%
H:
1.29%
C:
0.67%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-19.54%
|
O:
0.08%
H:
2.08%
C:
1.3%
DCPH
|
$14.6
-0.48%
-0.48%
610K
|
Health Technology
|
12.67%
|
O:
4.95%
H:
2.5%
C:
1.18%
pharmaceuticals
financial
results
Innovent Announces the Preclinical Results of IBI363 (PD-1/IL-2 Bispecific Antibody Fusion Protein) were Published in Nature Cancer
Published:
2023-08-08
(Crawled : 03:00)
- prnewswire.com
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-10.41%
|
O:
1.09%
H:
0.0%
C:
0.0%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-18.4%
|
O:
2.58%
H:
0.41%
C:
-1.13%
ibi363
antibody
cancer
preclinical
results
Merus Announces Financial Results for the Second Quarter 2023 and Provides Business Update
Published:
2023-08-07
(Crawled : 21:00)
- globenewswire.com
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
61.06%
|
O:
11.43%
H:
6.32%
C:
3.08%
MRUS
|
$40.435
1.57%
1.55%
710K
|
Health Technology
|
61.48%
|
O:
3.79%
H:
1.72%
C:
-11.69%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-18.4%
|
O:
2.58%
H:
0.41%
C:
-1.13%
business
update
financial
results
Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published:
2023-08-01
(Crawled : 15:00)
- biospace.com/
TAK
|
News
|
$13.36
0.91%
-0.52%
1.6M
|
Health Technology
|
-12.45%
|
O:
-2.23%
H:
2.28%
C:
1.34%
XNCR
|
$18.19
-1.03%
-1.04%
490K
|
Health Technology
|
-25.03%
|
O:
-0.74%
H:
0.0%
C:
0.0%
REPL
|
$6.43
-0.31%
-0.31%
550K
|
Health Technology
|
-68.77%
|
O:
2.63%
H:
1.14%
C:
-2.65%
MOR
|
News
|
$17.97
-0.06%
-0.06%
330K
|
Health Technology
|
144.49%
|
O:
-0.14%
H:
4.77%
C:
4.77%
MGNX
|
$15.41
-1.28%
-1.3%
770K
|
Health Technology
|
223.06%
|
O:
0.0%
H:
4.19%
C:
2.31%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-18.52%
|
O:
2.75%
H:
0.44%
C:
-2.72%
financial
results
Syndax and Incyte Announce Positive Topline Results from the Pivotal AGAVE-201 Trial of Axatilimab in Chronic Graft-Versus-Host Disease
Published:
2023-07-24
(Crawled : 11:00)
- prnewswire.com
SNDX
|
$20.97
0.82%
0.81%
670K
|
Health Technology
|
-1.41%
|
O:
8.18%
H:
2.39%
C:
-5.35%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-19.06%
|
O:
0.17%
H:
0.37%
C:
-1.24%
agave-201
disease
positive
topline
trial
results
Incyte to Report Second Quarter Financial Results - July 11, 2023
Published:
2023-07-11
(Crawled : 13:00)
- biospace.com/
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-16.11%
|
O:
0.44%
H:
1.16%
C:
1.09%
report
financial
results
Syros Reports First Quarter 2023 Financial Results and Provides a Corporate Update
Published:
2023-05-10
(Crawled : 13:00)
- biospace.com/
SYRS
|
$4.99
9.91%
9.02%
150K
|
Health Technology
|
60.45%
|
O:
0.0%
H:
15.7%
C:
10.29%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-19.84%
|
O:
0.29%
H:
0.07%
C:
-1.6%
update
financial
results
Zai Lab Announces First Quarter 2023 Financial Results and Corporate Updates
Published:
2023-05-09
(Crawled : 20:00)
- globenewswire.com
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
14.34%
|
O:
-0.21%
H:
0.32%
C:
-0.07%
ZLAB
|
$14.97
6.4%
6.01%
460K
|
Health Technology
|
-57.61%
|
O:
4.89%
H:
6.5%
C:
1.13%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
14.37%
|
O:
0.17%
H:
0.07%
C:
-0.17%
NVCR
|
$11.82
-2.23%
-2.28%
810K
|
Health Technology
|
-83.1%
|
O:
1.11%
H:
1.89%
C:
0.97%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
24.33%
|
O:
-2.41%
H:
5.41%
C:
3.75%
KRTX
|
$329.83
0.0%
1.9M
|
Health Technology
|
51.29%
|
O:
1.07%
H:
1.21%
C:
0.62%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-19.84%
|
O:
0.29%
H:
0.07%
C:
-1.6%
BPMC
|
$90.69
4.42%
4.23%
780K
|
Health Technology
|
67.08%
|
O:
1.36%
H:
0.13%
C:
-1.89%
results
Innovent Updates the Results from the ORIENT-31 Study of Sintilimab Plus Chemotherapy With or Without Bevacizumab in Patients with EGFR-TKI failed EGFR-mutated Non-Squamous Non-Small Cell Lung Cancer in the Lancet Respiratory Medicine
Published:
2023-05-08
(Crawled : 00:00)
- prnewswire.com
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
70.95%
|
O:
-0.38%
H:
2.06%
C:
1.53%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-15.96%
|
O:
0.59%
H:
0.0%
C:
0.0%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-22.0%
|
O:
0.03%
H:
0.17%
C:
-1.19%
rient-31
lung
lancet
respiratory
cancer
cell
plus
results
study
← Previous
1
2
3
4
Next →
Gainers vs Losers
75%
25%
Top 10 Gainers
MTTR
|
News
M
|
$4.78
174.71%
63.6%
72M
|
AGBA
|
$2.565
105.2%
51.27%
200M
|
Finance
MLEC
|
$2.44
74.29%
42.62%
78M
|
n/a
EDBL
|
News
|
$6.28
67.02%
40.13%
16M
|
ATGL
|
$2.91
48.81%
32.8%
180K
|
ZAPP
|
$0.2175
47.16%
32.05%
16M
|
n/a
ONFO
|
$0.6075
38.38%
27.74%
7.3M
|
n/a
VIVK
|
$1.48
38.32%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.8M
|
SDIG
A
|
$3.635
35.13%
26.0%
1M
|
Your saved searches
Save your searches and get alerts when important news are released.